A deep understanding of the neural basis of cognitive impairment in schizophrenia is critical for the development of treatments for this disorder, as cognitive dysfunction can predict clinical outcomes such a relapse frequency and everyday functioning. Achieving this level of understanding is possible by studying post-mortem human brain tissue. However, thus far, scientists have been prevented from doing so due to significant challenges related to the absence of information on the cognitive aptitude of postmortem subjects.